These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 30778653)
41. Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients. Norcini Pala A; Steca P; Bagrodia R; Helpman L; Colangeli V; Viale P; Wainberg ML Brain Behav Immun; 2016 Aug; 56():105-13. PubMed ID: 26883521 [TBL] [Abstract][Full Text] [Related]
42. Interleukin-6: a possible inflammatory link between vitiligo and type 1 diabetes. Farhan J; Al-Shobaili HA; Zafar U; Al Salloom A; Meki AR; Rasheed Z Br J Biomed Sci; 2014; 71(4):151-7. PubMed ID: 25562992 [TBL] [Abstract][Full Text] [Related]
44. Neuro-oncology family caregivers are at risk for systemic inflammation. Sherwood PR; Price TJ; Weimer J; Ren D; Donovan HS; Given CW; Given BA; Schulz R; Prince J; Bender C; Boele FW; Marsland AL J Neurooncol; 2016 May; 128(1):109-118. PubMed ID: 26907491 [TBL] [Abstract][Full Text] [Related]
45. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s). El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747 [TBL] [Abstract][Full Text] [Related]
46. Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes. Grossmann V; Schmitt VH; Zeller T; Panova-Noeva M; Schulz A; Laubert-Reh D; Juenger C; Schnabel RB; Abt TG; Laskowski R; Wiltink J; Schulz E; Blankenberg S; Lackner KJ; Münzel T; Wild PS Diabetes Care; 2015 Jul; 38(7):1356-64. PubMed ID: 25877811 [TBL] [Abstract][Full Text] [Related]
47. Serum IL-6 levels and oxidation rate of LDL cholesterol were related to depressive symptoms independent of omega-3 fatty acids among female hospital and nursing home workers in Japan. Tsuboi H; Sakakibara H; Tatsumi A; Yamakawa-Kobayashi K; Matsunaga M; Kaneko H; Shimoi K J Affect Disord; 2019 Apr; 249():385-393. PubMed ID: 30818247 [TBL] [Abstract][Full Text] [Related]
48. Eveningness Is Associated With Greater Depressive Symptoms in Type 2 Diabetes Patients: A Study in Two Different Ethnic Cohorts. Saetung S; Nimitphong H; Siwasaranond N; Manodpitipong A; Crowley SJ; Hood MM; Reutrakul S Behav Sleep Med; 2019; 17(3):291-301. PubMed ID: 28617043 [TBL] [Abstract][Full Text] [Related]
49. [Longitudinal associations between depressive symptoms and type 2 diabetes and their impact on mortality in primary care patients]. Pieper L; Dirmaier J; Klotsche J; Thurau C; Pittrow D; Lehnert H; März W; Koch U; Wittchen HU Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jan; 54(1):98-107. PubMed ID: 21246335 [TBL] [Abstract][Full Text] [Related]
50. Social determinants of inflammatory markers linking depression and type 2 diabetes among women: A scoping review. Perez N; He N; Wright F; Condon E; Weiser S; Aouizerat B J Psychosom Res; 2024 Sep; 184():111831. PubMed ID: 38905780 [TBL] [Abstract][Full Text] [Related]
51. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study. Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259 [TBL] [Abstract][Full Text] [Related]
52. Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men. Su SC; Sun MT; Wen MJ; Lin CJ; Chen YC; Hung YJ Int J Psychiatry Med; 2011; 42(3):211-26. PubMed ID: 22439294 [TBL] [Abstract][Full Text] [Related]
53. Listening to the heart-brain talk: persistent depressive symptoms are associated with hsCRP in apparently healthy individuals at high risk for coronary artery disease. Azar R; Nolan RP; Stewart DE Eur J Prev Cardiol; 2012 Aug; 19(4):857-63. PubMed ID: 21729973 [TBL] [Abstract][Full Text] [Related]
54. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184 [TBL] [Abstract][Full Text] [Related]
55. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Oberbach A; Tönjes A; Klöting N; Fasshauer M; Kratzsch J; Busse MW; Paschke R; Stumvoll M; Blüher M Eur J Endocrinol; 2006 Apr; 154(4):577-85. PubMed ID: 16556721 [TBL] [Abstract][Full Text] [Related]
56. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. Montinaro V; Iaffaldano GP; Granata S; Porcelli P; Todarello O; Schena FP; Pertosa G Clin Nephrol; 2010 Jan; 73(1):36-43. PubMed ID: 20040350 [TBL] [Abstract][Full Text] [Related]
57. Individuals with diabetes mellitus with and without depressive symptoms: could social network explain the comorbidity? Kozel D; Marusić A Psychiatr Danub; 2006 Jun; 18(1-2):12-8. PubMed ID: 16804495 [TBL] [Abstract][Full Text] [Related]
58. Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. Einvik G; Flyvbjerg A; Hrubos-Strøm H; Randby A; Frystyk J; Bjerre M; Namtvedt SK; Kristiansen HA; Nordhus IH; Somers VK; Dammen T; Omland T J Affect Disord; 2013 Mar; 145(3):400-4. PubMed ID: 22862888 [TBL] [Abstract][Full Text] [Related]
60. Is the association between depressive symptoms and glucose bidirectional? A population-based study. Wesołowska K; Elovainio M; Hintsa T; Jokela M; Pulkki-Råback L; Lipsanen J; Juonala M; Raitakari O; Keltikangas-Järvinen L Health Psychol; 2018 Jul; 37(7):603-612. PubMed ID: 29672099 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]